Whitepaper
9 Feb 2023

Drug Formulation Development Process Notes From A CDMO

PDF 4.7 MB
Download

Pharma R&D productivity has remained stagnant in the new millennium, despite record industry growth. While new technology has improved productivity in nearly every other sector, efficiency in pharmaceutical R&D is declining (or as described by MedCity News — “broken”).What obstacles are in the way of improving productivity in the pharmaceutical industry? How can we meet these challenges? At Ascendia Pharma, we’re proud to have innovative strategies in place to help our clients get their drugs from R&D to market faster.

Content provided by our supplier

Ascendia Pharmaceuticals

  • US
  • 2017
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
View company profile

Other Content from Ascendia Pharmaceuticals (3)

  • Pandemic and transformative technologies fuel growth in pharma outsourcing sector: CPHI North America panel

    News Pandemic and transformative technologies fuel growth in pharma outsourcing sector: CPHI North America panel

    Transformative technologies and the opportunities afforded by the COVID-19 pandemic have spurred investment in the life sciences outsourcing sector, according to a panel of industry experts speaking at CPHI North America on Monday.
    27 Jul 2021
  • 4 Factors Affecting Solubility of Drugs

    News 4 Factors Affecting Solubility of Drugs

    Bringing a new drug—or a new formula—to market is an exciting time for pharmaceutical companies, but getting the formulation correct can be challenging. Low aqueous solubility is a top concern encountered with formulation development of new chemical entities (NCEs). Improper drug solubility can lead to suboptimal drug delivery and absorption, resulting in ineffective drug efficacy and side effects. That's why solubility of drugs must be evaluated in the early stages of drug discovery.
    21 Jul 2021
  • Formulation Forum: Nanosuspension Dosage Forms

    News Formulation Forum: Nanosuspension Dosage Forms

    Nano-formulation of poorly water-soluble drugs has brought two proven benefits to commercial drug products. One is it enhances drug dissolution and oral bioavailability. Second, nano-formulation increases drug loading and release duration for parenteral drug delivery. In the June issue of issue of Drug Development & Delivery, Ascendia Pharma CEO Jim Huang, Ph.D., discusses one method of preparing nanosuspensions in his Formulation Forum column.
    21 Jul 2021